TCRBV families | CD4+ T cells | CD8+ T cells | Total PBMCs |
---|---|---|---|
 | Incidence (%)b | Incidence (%)b | Incidence (%)b |
1 | 8 | 5 | 7 |
2 | 9 | 8 | 7 |
3 | 14 (35.0) | 8 | 11 (28.2) |
4 | 7 | 5 | 7 |
5.1 | 15 (37.5) | 9 | 12 (30.8) |
5.2 | 7 | 9 | 8 |
6 | 8 | 5 | 6 |
7 | 7 | 6 | 4 |
8 | 10 (25.0) | 7 | 6 |
9 | 7 | 5 | 3 |
10 | 7 | 6 | 8 |
11 | 8 | 3 | 7 |
12 | 24 (60.0) | 16 (41.0) | 21 (53.8) |
13.1 | 16 (40.0) | 12 (30.8) | 12 (30.8) |
13.2 | 15 (37.5) | 13 (33.3) | 15 (38.5) |
14 | 11 (27.5) | 8 | 8 |
15 | 9 | 5 | 7 |
16 | 7 | 5 | 2 |
17 | 6 | 6 | 5 |
18 | 10 (25.0) | 9 | 8 |
19 | 7 | 7 | 5 |
20 | 14 (35.0) | 8 | 11 (28.2) |
21 | 7 | 5 | 6 |
22 | 7 | 6 | 5 |
23 | 10 (25.0) | 7 | 8 |
24 | 16 (40.0) | 10 (25.6) | 12 (30.8) |
Total no. of skewed BV (average ratio for a case) | 266 (6.65) c | 193 (4.95) c, d | 211 (5.41) c, d |
No. of subjects examined with normal pattern (ratio, %) | 2 (4.76) e | 3 (7.14) e | 3 (7.14)e |
No. of subjects examined | 42 | 42 | 42 |